バイオプロセス技術の世界市場：製品別、用途別、エンドユーザー別、地域範囲別、予測

バイオプロセス技術の市場規模と予測

バイオプロセス技術市場規模は、2024年に287億米ドルと評価され、2026～2032年にかけて10.70%のCAGRで成長し、2032年には603億米ドルに達すると予測されます。

バイオプロセス技術とは、生物学的材料の生産を強化する製品やプロセスを開発するために、生きた細胞やその成分を使用することを指します。

この技術は、効率性と持続可能性のために生物学的システムを活用するため、医薬品、酵素、バイオ燃料、食品の生産を含む様々な用途において極めて重要です。

バイオプロセス技術の将来は有望であり、合成生物学、ゲノム科学、自動化の進歩によって、個別化医療、再生可能エネルギー、サステイナブル農業などのセグメントで、より効率的な生産方法と革新的な応用が期待されています。

バイオプロセス技術の世界市場力学

世界のバイオプロセス技術市場を形成している主要市場力学は以下の通りです。

主要市場促進要因

バイオ医薬品需要の拡大：バイオ医薬品の需要拡大：バイオ医薬品セクタは、慢性疾患の増加や個別化医療の進歩に牽引され、急速に拡大しています。Global Biopharmaceutical Market Report 2023によると、同市場は2025年までに3兆8,000億米ドルに達し、CAGR8.6%で成長すると予想されています。

バイオテクノロジーの進歩：遺伝子編集や合成生物学を含むバイオテクノロジーの革新は、バイオプロセスの効率と生産性を高めています。米国国立衛生ラボ（NIH）の報告書によると、バイオテクノロジーの研究開発への投資は2021年に約650億米ドルに達し、このセグメントの技術進歩への強いコミットメントを示しています。

持続可能性への注目の高まり：様々な産業、特にバイオ燃料や生分解性材料の生産において、サステイナブル実践が重視されるようになってきています。国際再生可能エネルギー機関（IRENA）の報告によると、世界のバイオ燃料市場はCAGR6.5%で成長し、2027年には1,850億米ドルに達すると予測されています。

政府の支援と資金援助：世界の多くの政府は、バイオプロセス技術開発を支援するため、多額の資金とインセンティブを提供しています。例えば米国エネルギー省（DOE）は、バイオエネルギー技術の発展のために2023年に5,700万米ドルを投資すると発表しており、これはバイオプロセスの革新に対する政府の強力なバックアップを反映しています。

主要課題

規制上のハードル：バイオプロセス技術部門は、製品の承認を遅らせ、コストを増大させる複雑な規制要件に直面しています。こうした規制を乗り切るには、多大な時間とリソースを必要とします。

高い生産コスト：設備や原料を含むバイオプロセス技術の初期投資は多額になる可能性があり、その結果、生産コストが高くなり、中小企業の市場参入を妨げる可能性があります。

拡大性の問題：実験室規模のプロセスから商業規模の生産への移行は、スケールアップ中の製品の品質や一貫性の維持などの課題をもたらす可能性があります。

人材不足：バイオプロセスにおける熟練した専門家に対する需要は高まっているが、有能な人材が不足しているため、産業内の技術革新や開発が制限される可能性があります。

主要動向

オートメーションとAIの統合：バイオプロセスにおけるオートメーションと人工知能の利用の増加は、効率を高め、ヒューマンエラーを減らし、プロセスのリアルタイムモニタリングと最適化を可能にしています。

連続処理へのシフト：製造時間の短縮や製品品質の向上など、従来型バッチ処理に比べ利点のある連続バイオプロセスへの移行が進んでいます。

個別化医療への注目：個別化医療の台頭は、バイオプロセス技術の革新を促し、個々の患者のニーズに合わせた治療法の開発につながります。

サステイナブル実践とグリーン技術：世界の持続可能性の目標に沿うため、再生可能資源の使用や廃棄物の最小化など、サステイナブル手法やエコフレンドリー技術の採用が進んでいます。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査スケジュール
• 前提条件
• 限界

第2章 調査手法

• データマイニング
• 二次調査
• 一次調査
• 専門家の助言
• クオリティチェック
• 最終レビュー
• データの三角測量
• ボトムアップアプローチ
• トップダウンアプローチ
• 調査の流れ
• データソース
• 産業専門家による主要な洞察

第3章 エグゼクティブサマリー

• 市場概要
• 世界のバイオプロセス技術生態マッピング
• 世界のバイオプロセス技術市場の魅力
• 世界のバイオプロセス技術絶対的収益機会
• バイオプロセス技術の世界市場の地理的洞察
• バイオプロセス技術の世界市場：タイプ別
• バイオプロセス技術の世界市場：用途別
• バイオプロセス技術の世界市場：エンドユーザー別
• 今後の市場機会
• 世界市場内訳

第4章 市場展望

• バイオプロセス技術の世界市場展望
• 市場促進要因
  • 疾病負担の増加。
  • バイオプロセス開発のアウトソーシング動向の進行
• 市場抑制要因
  • 高い設備投資と高価な機器
  • 厳しい政府規制。
• 可能性
  • バイオテクノロジー研究開発投資の増加
  • 強力なバイオ医薬品パイプライン
• COVID-19が世界市場に与える影響
• ポーターのファイブフォース分析
  • 新規参入業者の脅威
  • 代替品の脅威
  • 供給企業の交渉力
  • 買い手の交渉力
  • 競争企業間の敵対関係の強さ
• マクロ経済分析
• バリューチェーン分析

第5章 製品別市場

• 概要
• バイオプロセス機器
• バイオプロセスサービス

第6章 用途別市場

• 概要
• 医薬品
• バイオテクノロジー
• 飲食品
• 環境管理

第7章 エンドユーザー別市場

• 概要
• バイオ医薬品企業
• 学術・研究機関
• 製造受託機関

第8章 地域別市場

• 概要
• 北米
  • 北米市場スナップショット
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州市場スナップショット
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他の欧州
• アジア太平洋
  • アジア太平洋市場スナップショット
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• ラテンアメリカ
  • ラテンアメリカ市場スナップショット
  • ブラジル
  • アルゼンチン
  • その他のラテンアメリカ
• 中東・アフリカ
  • 中東・アフリカ市場スナップショット
  • アラブ首長国連邦
  • サウジアラビア
  • 南アフリカ
  • その他の中東・アフリカ

第9章 競合情勢

• 概要
• 競合シナリオ
• 各社の市場ランキング分析
• 地域別フットプリント
• 企業の産業別フットプリント
• エースマトリックス
  • アクティブ
  • カッティングエッジ
  • エマージング
  • イノベーター

第10章 企業プロファイル

• GE HEALTHCARE COMPANY
• THERMO FISHER SCIENTIFIC
• DANAHER CORPORATION
• LCG GROUP
• MERCK GROUP
• LONZA GROUP AG
• SARTORIUS AG.
• CORNING INCORPORATED
• BIO-RAD LABORATORIES, INC.

LIST OF TABLES

• TABLE1 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES
• TABLE 2 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 3 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLES & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 4 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 5 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 6 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY END-USER, 2022 - 2030 (USD MILLION)
• TABLE 7 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY GEOGRAPHY, 2022 - 2030 (USD MILLION)
• TABLE 8 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY COUNTRIES, 2022 - 2030 (USD MILLION)
• TABLE 9 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE10 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE11 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE12 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE13 NORTH AMERICA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE14 U.S. BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE15 U.S. BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE16 U.S. BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE17 U.S.BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE18 U.S.BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE19 CANADABIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 20 CANADA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 21 CANADA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 22 CANADA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 23 CANADA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE 24 MEXICO BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 25 MEXICO BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 26 MEXICO BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 27 MEXICO BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 28 MEXICO BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE 29 EUROPE BIOPROCESS TECHNOLOGY MARKET, BY COUNTRY, 2022 - 2030 (USD MILLION)
• TABLE 30 EUROPE BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 31 EUROPEBIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 32 EUROPE BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 33 EUROPE BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 34 EUROPE BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE 35 GERMANY BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 36 GERMANY BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 37 GERMANY BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 38 GERMANY BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 39 GERMANY BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE 40 U.K BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 41 U.K BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 42 U.K BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 43 U.K BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 44 U.K BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE 45 FRANCE BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 46 FRANCE BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 47 FRANCE BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 48 FRANCE BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 49 FRANCE BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE 50 ITALY BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 51 ITALY BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 52 ITALY BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 53 ITALY BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 54 ITALY BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE 55 SPAIN BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 56 SPAIN BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 57 SPAIN BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 58 SPAIN BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 59 SPAIN BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE 60 REST OF EUROPE BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 61 REST OF EUROPE BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 62 REST OF EUROPE BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 63 REST OF EUROPE BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 64 REST OF EUROPE BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE 65 ASIA PACIFIC BIOPROCESS TECHNOLOGY MARKET, BY COUNTRY, 2022 - 2030 (USD MILLION)
• TABLE 66 ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 67 ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 68 ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 69 ASIA-PACIFIC BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 70 ASIA-PACIFIC BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE 71 CHINA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 72 CHINA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 73 CHINA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 74 CHINA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 75 CHINA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE 76 JAPAN BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 77 JAPAN BIOPROCESS TECHNOLOGY MARKET, BY CONSUMAABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 78 JAPAN BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 79 JAPAN BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 80 JAPAN BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE 81 INDIA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 82 INDIA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE A& ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 83 INDIA BIOPROCESS TECHNOLOGY MARKET, BY INTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 84 INDIABIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 85 INDIA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE 86 REST OF ASIA-PACIFIC BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 87 REST OF ASIA PACIFICBIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 88 REST OF ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 89 REST OF ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 90 REST OF ASIA-PACIFICBIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE 91 LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY COUNTRY, 2022 - 2030 (USD MILLION)
• TABLE 92 LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 93 LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 94 LATIN AMERICABIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE 95 LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE 96 LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE 97 BRAZIL BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE 98 BRAZIL BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE 99 BRAZIL BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE100 BRAZIL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE101 BRAZIL BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE102 ARGENTINA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE103 ARGENTINA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE104 ARGENTINA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE105 ARGENTINA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE106 ARGENTINA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE107 REST OF LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE108 REST OF LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE109 REST OF LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE110 REST OF LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE111 REST OF LATIN AMERICA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION
• TABLE112 MIDDLE EAST AND AFRICA BIOPROCESS TECHNOLOGY MARKET, BY COUNTRY, 2022 - 2030 (USD MILLION)
• TABLE113 MIDDLE EAST & AFRICA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE114 MIDDLE EAST & AFRICABIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE115 MIDDLE EAST & AFRICABIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE116 MIDDLE EAST & AFRICABIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE117 MIDDLE EAST & AFRICA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE118 UAE BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE119 UAE BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE120 UAE BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE121 UAE BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE122 UAE BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE123 SAUDI ARABIA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE124 SAUDI ARABIA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE125 SAUDI ARABIA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE126 SAUDI ARABIA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE127 SAUDI ARABIA BIOPROCESS TECHNOLOGY MARKET, BY END USER, 2022 - 2030 (USD MILLION)
• TABLE128 SOUTH AFRICA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE129 SOUTH AFRICA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE130 SOUTH AFRICA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE131 SOUTH AFRICA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE132 SOUTH AFRICA BIOPROCESS TECHNOLOGY MARKET, BY END-USER, 2022 - 2030 (USD MILLION)
• TABLE133 REST OF MEA BIOPROCESS TECHNOLOGY MARKET, BY TYPE, 2022 - 2030 (USD MILLION)
• TABLE134 REST OF MEA BIOPROCESS TECHNOLOGY MARKET, BY CONSUMABLE & ACCESSORIES, 2022 - 2030 (USD MILLION)
• TABLE135 REST OF MEA BIOPROCESS TECHNOLOGY MARKET, BY INSTRUMENTS, 2022 - 2030 (USD MILLION)
• TABLE136 REST OF MEA BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION, 2022 - 2030 (USD MILLION)
• TABLE137 REST OF MEA BIOPROCESS TECHNOLOGY MARKET, BY END-USER, 2022 - 2030 (USD MILLION)
• TABLE138 COMPANY MARKET RANKING ANALYSIS
• TABLE139 COMPANY REGIONAL FOOTPRINT
• TABLE140 COMPANY INDUSTRY FOOTPRINT
• TABLE141 GE HEALTHCARE COMPANY: PRODUCT BENCHMARKING
• TABLE142 GE HEALTHCARE: KEY DEVELOPMENTS
• TABLE143 GE HEALTHCARE: WINNING IMPERATIVES
• TABLE144 THERMO FISHER SCIENTIFIC: PRODUCT BENCHMARKING
• TABLE145 THERMO FISHER SCIENTIFIC: KEY DEVELOPMENTS
• TABLE146 THERMO FISHER SCIENTIFIC: WINNING IMPERATIVES
• TABLE147 DANAHER CORPORATION: PRODUCT BENCHMARKING
• TABLE148 DANAHER CORPORATION: WINNING IMPERATIVES
• TABLE149 LCG GROUP: PRODUCT BENCHMARKING
• TABLE150 MERCK GROUP: PRODUCT BENCHMARKING
• TABLE151 LONZA GROUP AG: PRODUCT BENCHMARKING
• TABLE152 SARTORIUS AG: PRODUCT BENCHMARKING
• TABLE153 CORNING INCORPORATED: PRODUCT BENCHMARKING
• TABLE154 BIO-RAD LABORATORIES, INC.: PRODUCT BENCHMARKING

LIST OF FIGURES

• FIGURE1 GLOBAL BIOPROCESS TECHNOLOGY MARKET SEGMENTATION
• FIGURE 2 RESEARCH TIMELINES
• FIGURE 3 DATA TRIANGULATION
• FIGURE 4 MARKET RESEARCH FLOW
• FIGURE 5 DATA SOURCES
• FIGURE 6 KEY INSIGHTS FROM INDUSTRY EXPERTS
• FIGURE 7 GLOBAL BIOPROCESS TECHNOLOGY MARKET GEOGRAPHICALINSIGHTS, 2023-2030
• FIGURE 8 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BYTYPE(USD MILLION)
• FIGURE 9 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION (USD MILLION)
• FIGURE10 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY END USER (USD MILLION)
• FIGURE11 FUTURE MARKET OPPORTUNITIES
• FIGURE12 NORTH AMERICA DOMINATED THE MARKET IN 2021
• FIGURE13 GLOBAL BIOPROCESS TECHNOLOGY MARKET OUTLOOK
• FIGURE14 PORTER'S FIVE FORCES ANALYSIS
• FIGURE15 VALUE CHAIN ANALYSIS
• FIGURE16 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY TYPE
• FIGURE17 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION
• FIGURE18 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY END-USER
• FIGURE19 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY GEOGRAPHY, 2022 - 2030 (USD MILLION)
• FIGURE 20 KEY STRATEGIC DEVELOPMENTS
• FIGURE 21 ACE MATRIX
• FIGURE 22 GE HEALTHCARE: COMPANY INSIGHT
• FIGURE 23 GE HEALTHCARE COMPANY: BREAKDOWN
• FIGURE 24 GE HEALTHCARE: SWOT ANALYSIS
• FIGURE 25 THERMO FISHER SCIENTIFIC: COMPANY INSIGHT
• FIGURE 26 THERMO FISHER SCIENTIFIC: BREAKDOWN
• FIGURE 27 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS
• FIGURE 28 DANAHER CORPORATION: COMPANY INSIGHT
• FIGURE 29 DANAHER CORPORATION: BREAKDOWN
• FIGURE 30 DANAHER CORPORATION: SWOT ANALYSIS
• FIGURE 31 LCG GROUP: COMPANY INSIGHT
• FIGURE 32 MERCK GROUP: COMPANY INSIGHT
• FIGURE 33 MERCK GROUP: BREAKDOWN
• FIGURE 34 LONZA GROUP AG: COMPANY INSIGHT
• FIGURE 35 LONZA GROUP AG: BREAKDOWN
• FIGURE 36 SARTORIUS AG: COMPANY INSIGHT
• FIGURE 37 SARTORIUS AG: BREAKDOWN
• FIGURE 38 CORNING INCORPORATED: COMPANY INSIGHT
• FIGURE 39 CORNING INCORPORATED: BREAKDOWN
• FIGURE 40 BIO-RAD LABORATORIES, INC.: COMPANY INSIGHT
• FIGURE 41 CORNING INCORPORATED: BREAKDOWN

Bioprocess Technology Market Size And Forecast

Bioprocess Technology Market size was valued at USD 28.7 Billion in 2024 and is projected to reach USD 60.3 Billion by 2032, growing at a CAGR of 10.70% from 2026 to 2032.

Bioprocess technology refers to the use of living cells or their components to develop products and processes that enhance the production of biological materials.

This technology is pivotal in various applications, including the production of pharmaceuticals, enzymes, biofuels, and food products, as it leverages biological systems for efficiency and sustainability.

The future of bioprocess technology is promising, driven by advancements in synthetic biology, genomics, and automation, which are expected to lead to more efficient production methods and innovative applications in fields such as personalized medicine, renewable energy, and sustainable agriculture.

Global Bioprocess Technology Market Dynamics

The key market dynamics that are shaping the global bioprocess technology market include:

Key Market Drivers:

Growing Demand for Biopharmaceuticals: The biopharmaceutical sector is expanding rapidly, driven by the increasing prevalence of chronic diseases and advancements in personalized medicine. According to the Global Biopharmaceutical Market Report 2023, the market is expected to reach USD 3.8 trillion by 2025, growing at a compound annual growth rate (CAGR) of 8.6%.

Advancements in Biotechnology: Innovations in biotechnology, including gene editing and synthetic biology, are enhancing the efficiency and productivity of bioprocesses. A report from the National Institute of Health (NIH) highlights those investments in biotechnology research and development reached approximately USD 65 billion in 2021, indicating a strong commitment to technological advancements in this field.

Increasing Focus on Sustainability: There is a growing emphasis on sustainable practices in various industries, particularly in the production of biofuels and biodegradable materials. The International Renewable Energy Agency (IRENA) reports that the global biofuels market is projected to grow at a CAGR of 6.5%, reaching USD 185 billion by 2027.

Government Support and Funding: Many governments worldwide are providing substantial funding and incentives to support bioprocess technology development. For instance, the U.S. Department of Energy (DOE) announced an investment of USD 57 million in 2023 to advance bioenergy technologies, reflecting strong governmental backing for bioprocess innovations.

Key Challenges:

Regulatory Hurdles: The bioprocess technology sector faces complex regulatory requirements that can delay product approvals and increase costs. Navigating these regulations requires significant time and resources.

High Production Costs: The initial investment for bioprocess technology, including equipment and raw materials, can be substantial, leading to high production costs that may hinder market entry for smaller companies.

Scalability Issues: Transitioning from laboratory-scale processes to commercial-scale production can pose challenges, including maintaining product quality and consistency during scale-up.

Talent Shortage: There is a growing demand for skilled professionals in bioprocessing, but a shortage of qualified personnel can limit innovation and development within the industry.

Key Trends:

Integration of Automation and AI: The increasing use of automation and artificial intelligence in bioprocessing is enhancing efficiency, reducing human error, and enabling real-time monitoring and optimization of processes.

Shift towards Continuous Processing: There is a trend toward continuous bioprocessing, which offers advantages over traditional batch processing, such as reduced production time and improved product quality.

Focus on Personalized Medicine: The rise of personalized medicine is driving innovation in bioprocess technology, leading to the development of tailored therapies that meet individual patient needs.

Sustainable Practices and Green Technologies: The industry is increasingly adopting sustainable practices and green technologies, such as using renewable resources and minimizing waste, to align with global sustainability goals.

Global Bioprocess Technology Market Regional Analysis

Here is a more detailed regional analysis of the global bioprocess technology market:

North America:

North America is the dominant region in the global bioprocess technology market, driven by its advanced biotechnology infrastructure, robust research and development initiatives, and strong presence of major pharmaceutical companies. The region is home to a large number of biopharmaceutical firms that invest heavily in innovative bioprocessing technologies. According to a report by the Biotechnology Innovation Organization (BIO), the U.S. biopharmaceutical sector generated over $300 billion in revenue in 2023, highlighting the significant economic impact of bioprocess technologies.

Additionally, government initiatives and funding have further supported the growth of the bioprocess technology sector. For instance, the National Institutes of Health (NIH) has allocated approximately $50 billion annually to support biomedical research, including advancements in bioprocessing technologies. This financial backing encourages the development and commercialization of new biopharmaceutical products, reinforcing North America's leadership in the market.

Asia Pacific:

The Asia Pacific region is the fastest-growing market for bioprocess technology, driven by rapid industrialization, increasing healthcare demands, and significant investments in biotechnology. Countries like China and India are emerging as key players due to their growing biopharmaceutical sectors and expanding manufacturing capabilities. According to a report by the Asian Development Bank (ADB), the biotechnology market in Asia is projected to grow at a CAGR of over 15% from 2024 to 2030, underscoring its rapid expansion.

Additionally, the supportive government policies in countries like China, which includes the "Made in China 2025" initiative aimed at enhancing the biotechnology sector, are propelling market growth. The increasing focus on research and development in bioprocess technologies to meet the rising demand for biologics and biosimilars is further driving this growth trajectory in the Asia Pacific region.

Global Bioprocess Technology Market: Segmentation Analysis

The Global Bioprocess Technology Market is segmented on the basis of Product, Application, End User, and Geography.

Bioprocess Technology Market, By Product

• Bioprocess Instruments
• Bioprocess Services

Based on Product, the Global Bioprocess Technology Market is segmented into Bioprocess Instruments and Bioprocess Services. The bioprocess instruments is the dominating segment, driven by the demand for advanced equipment such as bioreactors, fermenters, and analytical tools essential for biopharmaceutical production and research. However, the bioprocess services segment is the fastest growing, fueled by the increasing complexity of bioprocesses and the need for outsourcing specialized services like cell line development, process optimization, and regulatory compliance.

Bioprocess Technology Market, By Application

• Pharmaceuticals
• Biotechnology
• Food and Beverage
• Environmental Management

Based on Application, the Global Bioprocess Technology Market is segmented into Pharmaceuticals, Biotechnology, Food and Beverage and Environmental Management. The pharmaceuticals is the dominating segment, driven by high demand for biopharmaceuticals and advanced therapies. However, the biotechnology segment is the fastest-growing, propelled by innovations in genetic engineering, personalized medicine, and vaccine development.

Bioprocess Technology Market, By End User

• Biopharmaceutical Companies
• Academic and Research Institutes
• Contract Manufacturing Organizations

Based on End User, the Global Bioprocess Technology Market is segmented into Biopharmaceutical Companies, Academic and Research Institutes and Contract Manufacturing Organizations. Biopharmaceutical companies dominate the landscape, as they represent a significant portion of the overall market due to their substantial investments in research and development for drug production. However, the contract manufacturing organizations (CMOs) segment is witnessing the fastest growth, driven by the increasing trend of outsourcing production processes by biopharmaceutical companies looking to reduce costs and improve efficiency.

Bioprocess Technology Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on the Geography, the Global Bioprocess Technology Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America is the dominant region in the global bioprocess technology market, driven by its advanced biotechnology infrastructure, robust research and development initiatives, and strong presence of major pharmaceutical companies. The Asia Pacific region is the fastest-growing market for bioprocess technology, driven by rapid industrialization, increasing healthcare demands, and significant investments in biotechnology.

Key Players

The "Global Bioprocess Technology Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, General Electric Company (GE Healthcare), Eppendorf AG, Lonza Group Ltd., Becton, Dickinson and Company.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Global Bioprocess Technology Market: Recent Developments
• In August 2024 Merck KGaA announced a strategic partnership with Pfizer to enhance the bioprocessing capabilities for monoclonal antibody production. This collaboration aims to leverage Merck's advanced bioprocess technology platforms to improve efficiency and scalability in drug development.
• In July 2024 Thermo Fisher Scientific opened a new bioprocessing facility in Massachusetts, aimed at expanding its production capacity for cell culture media and other bioprocessing solutions.
• In June 2024 Sartorius completed the acquisition of a bioprocessing technology startup that specializes in cell culture systems. This acquisition aligns with Sartorius's strategy to strengthen its portfolio of innovative solutions for biopharmaceutical manufacturing.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 MARKET DEFINITION
• 1.2 MARKET SEGMENTATION
• 1.3 RESEARCH TIMELINES
• 1.4 ASSUMPTIONS
• 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

• 2.1 DATA MINING
• 2.2 SECONDARY RESEARCH
• 2.3 PRIMARY RESEARCH
• 2.4 SUBJECT MATTER EXPERT ADVICE
• 2.5 QUALITY CHECK
• 2.6 FINAL REVIEW
• 2.7 DATA TRIANGULATION
• 2.8 BOTTOM-UP APPROACH
• 2.9 TOP-DOWN APPROACH
• 2.10 RESEARCH FLOW
• 2.11 DATA SOURCES
• 2.12 KEY INSIGHTS FROM INDUSTRY EXPERTS

3 EXECUTIVE SUMMARY

• 3.1 MARKET OVERVIEW
• 3.2 GLOBAL BIOPROCESS TECHNOLOGY ECOLOGY MAPPING
• 3.3 GLOBAL BIOPROCESS TECHNOLOGY MARKET ATTRACTIVENESS
• 3.4 GLOBAL BIOPROCESS TECHNOLOGY ABSOLUTE MARKET OPPORTUNITY
• 3.5 GLOBAL BIOPROCESS TECHNOLOGY MARKET GEOGRAPHICAL INSIGHTS
• 3.6 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY TYPE(USD MILLION)
• 3.7 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY APPLICATION (USD MILLION)
• 3.8 GLOBAL BIOPROCESS TECHNOLOGY MARKET, BY END USER (USD MILLION)
• 3.9 FUTURE MARKET OPPORTUNITIES
• 3.10 GLOBAL MARKET SPLIT

4 MARKET OUTLOOK

• 4.1 GLOBAL BIOPROCESS TECHNOLOGY MARKET OUTLOOK
• 4.2 MARKET DRIVERS
  • 4.2.1 RISE IN DISEASE BURDEN.
  • 4.2.2 ONGOING TREND OF OUTSOURCING OF BIOPROCESS DEVELOPMENT
• 4.3 MARKET RESTRAINT
  • 4.3.1 HIGH CAPITAL INVESTMENT AND HIGH COST OF INSTRUMENTS
  • 4.3.2 STRINGENT GOVERNMENT REGULATIONS.
• 4.4 OPPORTUNITIES
  • 4.4.1 RISE IN RESEARCH AND DEVELOPMENT INVESTMENT FOR BIOTECHNOLOGY
  • 4.4.2 ROBUST BIOPHARMACEUTICAL PIPELINE
• 4.5 IMPACT OF COVID19 ON THE GLOBAL MARKET
• 4.6 PORTER'S FIVE FORCES ANALYSIS
  • 4.6.1 THREAT OF NEW ENTRANTS
  • 4.6.2 THREAT OF SUBSTITUTES
  • 4.6.3 BARGAINING POWER OF SUPPLIERS
  • 4.6.4 BARGAINING POWER OF BUYERS
  • 4.6.5 INTENSITY OF COMPETITIVE RIVALRY
• 4.7 MACROECONOMIC ANALYSIS
• 4.8 VALUE CHAIN ANALYSIS

5 MARKET, BY PRODUCT

• 5.1 OVERVIEW
• 5.2 Bioprocess Instruments
• 5.3 Bioprocess Services

6 MARKET, BY APPLICATION

• 6.1 OVERVIEW
• 6.2 Pharmaceuticals
• 6.3 Biotechnology
• 6.4 Food and Beverage
• 6.5 Environmental Management

7 MARKET, BY END-USER

• 7.1 OVERVIEW
• 7.2 Biopharmaceutical Companies
• 7.3 Academic and Research Institutes
• 7.4 Contract Manufacturing Organizations

8 MARKET, BY GEOGRAPHY

• 8.1 OVERVIEW
• 8.2 NORTH AMERICA
  • 8.2.1 NORTH AMERICA MARKET SNAPSHOT
  • 8.2.2 U.S.
  • 8.2.3 CANADA
  • 8.2.4 MEXICO
• 8.3 EUROPE
  • 8.3.1 EUROPE MARKET SNAPSHOT
  • 8.3.2 GERMANY
  • 8.3.3 U.K.
  • 8.3.4 FRANCE
  • 8.3.5 ITALY
  • 8.3.6 SPAIN
  • 8.3.7 REST OF EUROPE
• 8.4 ASIA PACIFIC
  • 8.4.1 ASIA PACIFIC MARKET SNAPSHOT
  • 8.4.2 CHINA
  • 8.4.3 JAPAN
  • 8.4.4 INDIA
  • 8.4.5 REST OF APAC
• 8.5 LATIN AMERICA
  • 8.5.1 LATIN AMERICA MARKET SNAPSHOT
  • 8.5.2 BRAZIL
  • 8.5.3 ARGENTINA
  • 8.5.4 REST OF LATIN AMERICA
• 8.6 MIDDLE EAST AND AFRICA
  • 8.6.1 MIDDLE EAST AND AFRICA MARKET SNAPSHOT
  • 8.6.2 UAE
  • 8.6.3 SAUDI ARABIA
  • 8.6.4 SOUTH AFRICA
  • 8.6.5 REST OF MIDDLE EAST AND AFRICA

9 COMPETITIVE LANDSCAPE

• 9.1 OVERVIEW
• 9.2 COMPETITIVE SCENARIO
• 9.3 COMPANY MARKET RANKING ANALYSIS
• 9.4 COMPANY REGIONAL FOOTPRINT
• 9.5 COMPANY INDUSTRY FOOTPRINT
• 9.6 ACE MATRIX
  • 9.6.1 ACTIVE
  • 9.6.2 CUTTING EDGE
  • 9.6.3 EMERGING
  • 9.6.4 INNOVATORS

10 COMPANY PROFILES

• 10.1 GE HEALTHCARE COMPANY
  • 10.1.1 COMPANY OVERVIEW
  • 10.1.2 COMPANY INSIGHTS
  • 10.1.3 SEGMENT BREAKDOWN
  • 10.1.4 PRODUCT BENCHMARKING
  • 10.1.5 KEY DEVELOPMENTS
  • 10.1.6 SWOT ANALYSIS
  • 10.1.7 WINNING IMPERATIVES
  • 10.1.8 CURRENT FOCUS & STRATEGIES
  • 10.1.9 THREAT FROM COMPETITION
• 10.2 THERMO FISHER SCIENTIFIC
  • 10.2.1 COMPANY OVERVIEW
  • 10.2.2 COMPANY INSIGHTS
  • 10.2.1 SEGMENT BREAKDOWN
  • 10.2.2 PRODUCT BENCHMARKING
  • 10.2.3 KEY DEVELOPMENTS
  • 10.2.4 WINNING IMPERATIVES
  • 10.2.5 CURRENT FOCUS & STRATEGIES
  • 10.2.6 THREAT FROM COMPETITION
  • 10.2.7 SWOT ANALYSIS
• 10.3 DANAHER CORPORATION
  • 10.3.1 COMPANY OVERVIEW
  • 10.3.2 COMPANY INSIGHTS
  • 10.3.3 SEGMENT BREAKDOWN
  • 10.3.4 PRODUCT BENCHMARKING
  • 10.3.5 WINNING IMPERATIVES
  • 10.3.6 CURRENT FOCUS & STRATEGIES
  • 10.3.7 THREAT FROM COMPETITION
  • 10.3.8 SWOT ANALYSIS
• 10.4 LCG GROUP
  • 10.4.1 COMPANY OVERVIEW
  • 10.4.2 COMPANY INSIGHTS
  • 10.4.3 PRODUCT BENCHMARKING
• 10.5 MERCK GROUP
  • 10.5.1 COMPANY OVERVIEW
  • 10.5.2 COMPANY INSIGHTS
  • 10.5.3 SEGMENT BREAKDOWN
  • 10.5.4 PRODUCT BENCHMARKING
• 10.6 LONZA GROUP AG
  • 10.6.1 COMPANY OVERVIEW
  • 10.6.2 COMPANY INSIGHTS
  • 10.6.3 SEGMENT BREAKDOWN
  • 10.6.4 PRODUCT BENCHMARKING
• 10.7 SARTORIUS AG.
  • 10.7.1 COMPANY OVERVIEW
  • 10.7.2 COMPANY INSIGHTS
  • 10.7.3 SEGMENT BREAKDOWN
  • 10.7.4 PRODUCT BENCHMARKING
• 10.8 CORNING INCORPORATED
  • 10.8.1 COMPANY OVERVIEW
  • 10.8.2 COMPANY INSIGHTS
  • 10.8.3 SEGMENT BREAKDOWN
  • 10.8.4 PRODUCT BENCHMARKING
• 10.9 BIO-RAD LABORATORIES, INC.
  • 10.9.1 COMPANY OVERVIEW
  • 10.9.2 COMPANY INSIGHTS
  • 10.9.3 SEGMENT BREAKDOWN
  • 10.9.4 PRODUCT BENCHMARKING